Global Proliferative Diabetic Retinopathy (PDR) Pipeline Report 2016 – Review 7 Companies & Drug Profiles – Research and Markets
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H1 2016" report to their offering. This report provides comprehensive information on the therapeutic development for Proliferative Diabetic Retinopathy (PDR), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, an
